A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy
This study has been terminated.
(Lack of efficacy demonstrated in study ICA-17043-10)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Information provided by:
First received: February 21, 2006
Last updated: September 10, 2007
Last verified: September 2007
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||June 2007|
|Estimated Primary Completion Date:||No date given|